"Die Schön Klinik Hamburg Eilbek ist als Akademisches Lehrkrankenhaus der Universität Hamburg mit mehr als 800 Betten und rund 1.600 Mitarbeitenden eines der größten Krankenhäuser in Hamburg. Wir bieten hochqualifizierte medizinische Spezialleistungen und sind gleichzeitig im Notfall rund um die Uhr für Sie da."

During the past decade, Schön Klinik Hamburg Eilbek conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schön Klinik Hamburg Eilbek" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Aesculap AG" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Cephalon, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schön Klinik Hamburg Eilbek" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator, "Jacek Cholewicki PhD" with 1 trials as a collaborator, "MSU Center for Orthopedic Research" with 1 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Schön Klinik Hamburg Eilbek" are "Rheumatoid Arthritis" (5 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Arthritis, Juvenile" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Degenerative Disc Disease" (1 trials). Many other conditions were trialed in "Schön Klinik Hamburg Eilbek" in a lesser frequency.

Most popular intervention types in "Schön Klinik Hamburg Eilbek" are "Drug" (12 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (4 trials), "Apremilast" (1 trials), "Bilateral approach for Laminoplasty" (1 trials) and "CEP-33457" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schön Klinik Hamburg Eilbek" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Schön Klinik Hamburg Eilbek". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Schön Klinik Hamburg Eilbek, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Schön Klinik Hamburg Eilbek, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".